| Efficacy and Safety of Eltrombopag in Chinese Patients with Chronic Immune Thrombocytopenia: Stage 2 Results from a Multicenter Phase III Study | |
| Yang, Renchi; Liu Xiaofan; Li, Junmin; Hou, Ming; Jie, Jin; Huang, Meijuan; Yu, Ziqiang; Xu, Xiaojun; Zhang, Xiaohui | |
| 2018 | |
| 会议名称 | 60th Annual Meeting of the American-Society-of-Hematology (ASH) |
| 会议日期 | DEC 01-04, 2018 |
| 卷号 | 132 |
| DOI | 10.1182/blood-2018-99-110501 |
| 收录类别 | CPCI-S ; SCIE |
| 会议录 | BLOOD
 |
| URL标识 | 查看原文 |
| 内容类型 | 会议论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6025506 |
| 专题 | 山东大学 |
| 作者单位 | 1.Inst Hematol & Blood Dis, Tianjin, Peoples R China. 2.Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, Tianjin, Peop |
| 推荐引用方式 GB/T 7714 | Yang, Renchi,Liu Xiaofan,Li, Junmin,et al. Efficacy and Safety of Eltrombopag in Chinese Patients with Chronic Immune Thrombocytopenia: Stage 2 Results from a Multicenter Phase III Study[C]. 见:60th Annual Meeting of the American-Society-of-Hematology (ASH). DEC 01-04, 2018. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论